IsmenePetrakisMD

Clinical Trials

• Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism Start of enrollment: 2003 Jun 01

  Completed

  Phase 2

• Naltrexone & SSRI in Alcoholics With Depression/PTSD Start of enrollment: 2001 Oct 01

  Completed

  Phase 3

• Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients Start of enrollment: 2004 May 01

  Completed

  Phase 2

• Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism Start of enrollment: 2006 Sep 01

  Completed

  Phase 3

• The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder Start of enrollment: 2012 Jun 01

  Withdrawn

  Phase 3

• Ketamine/Placebo Family History Positive Study Start of enrollment: 2001 Mar 01

  Completed

  Not Applicable

• GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence Start of enrollment: 2005 Nov 01

  Completed

  Not Applicable

• Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism Start of enrollment: 2001 Mar 01

  Completed

  Not Applicable

• Couples-based Behavioral Psychotherapy for Male Patients With Posttraumatic Stress Disorder and Alcohol Dependence Start of enrollment: 2008 Feb 01

  Withdrawn

  Phase 2, Phase 3

• Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence Start of enrollment: 2008 Mar 01

  Completed

  Phase 2, Phase 3

• Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD). Start of enrollment: 2009 Jan 01

  Completed

  Phase 3

• Ketamine for Depression and Alcohol Dependence Start of enrollment: 2012 Mar 01

  Completed

  Phase 1

• Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence Start of enrollment: 2013 Jun 01

  Completed

  Phase 2

• Minocycline's Effects on Alcohol Responses in Humans Start of enrollment: 2015 Jul 01

  Completed

  Phase 1

• Varenicline + Prazosin for Heavy Drinking Smokers Start of enrollment: 2014 Jul 01

  Completed

  Early Phase 1

• Fish Oil vs. Placebo on Subjective Effects of Alcohol Start of enrollment: 2017 Mar 02

  Completed

  Phase 1

• Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study Start of enrollment: 2021 Nov 09

  Completed

  Phase 1

• Effect of Allopregnanolone on Stress-induced Craving Start of enrollment: 2019 Jul 01

  Completed

  Phase 1

  Roles: Contact

• Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD Start of enrollment: 2019 May 20

  Terminated

  Phase 2

  Roles: Contact

• Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study Start of enrollment: 2024 Aug 13

  Not yet recruiting

  Phase 1

  Roles: Contact, Principal Investigator

• Join now to see all